These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 26166153)
21. Social cognition and neurocognition as predictors of conversion to psychosis in individuals at ultra-high risk. Kim HS; Shin NY; Jang JH; Kim E; Shim G; Park HY; Hong KS; Kwon JS Schizophr Res; 2011 Aug; 130(1-3):170-5. PubMed ID: 21620681 [TBL] [Abstract][Full Text] [Related]
22. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis. Liu CC; Hua MS; Hwang TJ; Chiu CY; Liu CM; Hsieh MH; Chien YL; Lin YT; Hwu HG Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138 [TBL] [Abstract][Full Text] [Related]
23. Outcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study. Amminger GP; Henry LP; Harrigan SM; Harris MG; Alvarez-Jimenez M; Herrman H; Jackson HJ; McGorry PD Schizophr Res; 2011 Sep; 131(1-3):112-9. PubMed ID: 21741219 [TBL] [Abstract][Full Text] [Related]
24. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state. de Wit S; Schothorst PF; Oranje B; Ziermans TB; Durston S; Kahn RS Eur Neuropsychopharmacol; 2014 Jun; 24(6):865-73. PubMed ID: 24636460 [TBL] [Abstract][Full Text] [Related]
25. Predictors of functional outcome in individuals at high clinical risk for psychosis at six years follow-up. Brandizzi M; Valmaggia L; Byrne M; Jones C; Iwegbu N; Badger S; McGuire P; Fusar-Poli P J Psychiatr Res; 2015 Jun; 65():115-23. PubMed ID: 25837413 [TBL] [Abstract][Full Text] [Related]
26. Olfactory identification deficits at identification as ultra-high risk for psychosis are associated with poor functional outcome. Lin A; Brewer WJ; Yung AR; Nelson B; Pantelis C; Wood SJ Schizophr Res; 2015 Feb; 161(2-3):156-62. PubMed ID: 25476117 [TBL] [Abstract][Full Text] [Related]
27. Transition to first episode psychosis in ultra high risk populations: does baseline functioning hold the key? Velthorst E; Nelson B; Wiltink S; de Haan L; Wood SJ; Lin A; Yung AR Schizophr Res; 2013 Jan; 143(1):132-7. PubMed ID: 23182438 [TBL] [Abstract][Full Text] [Related]
28. Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome. Simon AE; Grädel M; Cattapan-Ludewig K; Gruber K; Ballinari P; Roth B; Umbricht D Schizophr Res; 2012 Dec; 142(1-3):108-15. PubMed ID: 23025995 [TBL] [Abstract][Full Text] [Related]
29. Impairment in Social Functioning differentiates youth meeting Ultra-High Risk for psychosis criteria from other mental health help-seekers: A validation of the Italian version of the Global Functioning: Social and Global Functioning: Role scales. Lo Cascio N; Curto M; Pasqualetti P; Lindau JF; Girardi N; Saba R; Brandizzi M; Monducci E; Masillo A; Colafrancesco G; Solfanelli A; De Crescenzo F; Kotzalidis GD; Dario C; Ferrara M; Vicari S; Girardi P; Auther AM; Cornblatt BA; Correll CU; Fiori Nastro P Psychiatry Res; 2017 Jul; 253():296-302. PubMed ID: 28412612 [TBL] [Abstract][Full Text] [Related]
30. Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents. Armando M; Pontillo M; De Crescenzo F; Mazzone L; Monducci E; Lo Cascio N; Santonastaso O; Pucciarini ML; Vicari S; Schimmelmann BG; Schultze-Lutter F Schizophr Res; 2015 Dec; 169(1-3):186-192. PubMed ID: 26526751 [TBL] [Abstract][Full Text] [Related]
31. Sources of clinical distress in young people at ultra high risk of psychosis. Rapado-Castro M; McGorry PD; Yung A; Calvo A; Nelson B Schizophr Res; 2015 Jun; 165(1):15-21. PubMed ID: 25890793 [TBL] [Abstract][Full Text] [Related]
32. Clinical utility of the Calgary Depression Scale for Schizophrenia in individuals at ultra-high risk of psychosis. Rekhi G; Ng WY; Lee J Schizophr Res; 2018 Mar; 193():423-427. PubMed ID: 28712967 [TBL] [Abstract][Full Text] [Related]
33. Childhood sexual and physical abuse: age at exposure modulates impact on functional outcome in early psychosis patients. Alameda L; Ferrari C; Baumann PS; Gholam-Rezaee M; Do KQ; Conus P Psychol Med; 2015 Oct; 45(13):2727-36. PubMed ID: 26350397 [TBL] [Abstract][Full Text] [Related]
34. The effect of childhood adversity on 4-year outcome in individuals at ultra high risk for psychosis in the Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial. Kraan TC; Ising HK; Fokkema M; Velthorst E; van den Berg DPG; Kerkhoven M; Veling W; Smit F; Linszen DH; Nieman DH; Wunderink L; Boonstra N; Klaassen RMC; Dragt S; Rietdijk J; de Haan L; van der Gaag M Psychiatry Res; 2017 Jan; 247():55-62. PubMed ID: 27863320 [TBL] [Abstract][Full Text] [Related]
35. Childhood adversity and social functioning in psychosis: Exploring clinical and cognitive mediators. Palmier-Claus J; Berry K; Darrell-Berry H; Emsley R; Parker S; Drake R; Bucci S Psychiatry Res; 2016 Apr; 238():25-32. PubMed ID: 27086207 [TBL] [Abstract][Full Text] [Related]
36. Predictors of 10-year outcome of first-episode psychosis. White C; Stirling J; Hopkins R; Morris J; Montague L; Tantam D; Lewis S Psychol Med; 2009 Sep; 39(9):1447-56. PubMed ID: 19187566 [TBL] [Abstract][Full Text] [Related]
37. Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis. Lavoie S; Jack BN; Griffiths O; Ando A; Amminger P; Couroupis A; Jago A; Markulev C; McGorry PD; Nelson B; Polari A; Yuen HP; Whitford TJ Schizophr Res; 2018 Jan; 191():95-100. PubMed ID: 29132815 [TBL] [Abstract][Full Text] [Related]
38. Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Yung AR; Nelson B; Stanford C; Simmons MB; Cosgrave EM; Killackey E; Phillips LJ; Bechdolf A; Buckby J; McGorry PD Schizophr Res; 2008 Oct; 105(1-3):10-7. PubMed ID: 18765167 [TBL] [Abstract][Full Text] [Related]
39. Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up. Cropley VL; Lin A; Nelson B; Reniers RLEP; Yung AR; Bartholomeusz CF; Klauser P; Velakoulis D; McGorry P; Wood SJ; Pantelis C Schizophr Res; 2016 Jun; 173(3):152-158. PubMed ID: 26032566 [TBL] [Abstract][Full Text] [Related]
40. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]